GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MYND Life Sciences Inc (XCNQ:MYND) » Definitions » EV-to-Revenue

MYND Life Sciences (XCNQ:MYND) EV-to-Revenue : (As of Mar. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is MYND Life Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MYND Life Sciences's enterprise value is C$7.06 Mil. MYND Life Sciences's Revenue for the trailing twelve months (TTM) ended in Jul. 2024 was C$0.00 Mil. Therefore, MYND Life Sciences's EV-to-Revenue for today is .

The historical rank and industry rank for MYND Life Sciences's EV-to-Revenue or its related term are showing as below:

During the past 3 years, the highest EV-to-Revenue of MYND Life Sciences was -58.79. The lowest was -195.12. And the median was -94.13.

XCNQ:MYND's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.285
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-03-04), MYND Life Sciences's stock price is C$0.085. MYND Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Jul. 2024 was C$0.00. Therefore, MYND Life Sciences's PS Ratio for today is .


MYND Life Sciences EV-to-Revenue Historical Data

The historical data trend for MYND Life Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MYND Life Sciences EV-to-Revenue Chart

MYND Life Sciences Annual Data
Trend Oct21 Oct22 Oct23
EV-to-Revenue
- - -

MYND Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MYND Life Sciences's EV-to-Revenue

For the Biotechnology subindustry, MYND Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MYND Life Sciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MYND Life Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where MYND Life Sciences's EV-to-Revenue falls into.



MYND Life Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

MYND Life Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=7.064/0
=

MYND Life Sciences's current Enterprise Value is C$7.06 Mil.
MYND Life Sciences's Revenue for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MYND Life Sciences  (XCNQ:MYND) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

MYND Life Sciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.085/0
=

MYND Life Sciences's share price for today is C$0.085.
MYND Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MYND Life Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of MYND Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MYND Life Sciences Business Description

Traded in Other Exchanges
Address
105-2248 Elgin Avenue, Port Coquitlam, BC, CAN, V3C 2B2
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.